Regulated Proteolysis of NOTCH2 and NOTCH3 Receptors by ADAM10 and Presenilins

REFERENCES

• Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: cell fate control and signal integration in development. Science 284:770–776. http://dx.doi.org/10.1126/science.284.5415.770.
   PubMed Web of Science ®Google Scholar
• van Tetering G, van Diest P, Verlaan I, van der Wall E, Kopan R, Vooijs M. 2009. Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J. Biol. Chem. 284:31018–31027. http://dx.doi.org/10.1074/jbc.M109.006775.
   PubMed Web of Science ®Google Scholar
• Kopan R, Ilagan MX. 2009. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137:216–233. http://dx.doi.org/10.1016/j.cell.2009.03.045.
   PubMed Web of Science ®Google Scholar
• Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. 2004. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol. Cell. Biol. 24:9265–9273. http://dx.doi.org/10.1128/MCB.24.21.9265-9273.2004.
   PubMed Web of Science ®Google Scholar
• De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. 1999. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518–522. http://dx.doi.org/10.1038/19083.
   PubMed Web of Science ®Google Scholar
• Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, Bernstein A. 1999. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13:2801–2810. http://dx.doi.org/10.1101/gad.13.21.2801.
   PubMed Web of Science ®Google Scholar
• Hamada Y, Kadokawa Y, Okabe M, Ikawa M, Coleman JR, Tsujimoto Y. 1999. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 126:3415–3424.
   PubMedGoogle Scholar
• Krebs LT, Xue Y, Norton CR, Sundberg JP, Beatus P, Lendahl U, Joutel A, Gridley T. 2003. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 37:139–143. http://dx.doi.org/10.1002/gene.10241.
   PubMedGoogle Scholar
• Saxena MT, Schroeter EH, Mumm JS, Kopan R. 2001. Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. J. Biol. Chem. 276:40268–40273. http://dx.doi.org/10.1074/jbc.M107234200.
   PubMedGoogle Scholar
• Mizutani T, Taniguchi Y, Aoki T, Hashimoto N, Honjo T. 2001. Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members. Proc. Natl. Acad. Sci. U. S. A. 98:9026–9031. http://dx.doi.org/10.1073/pnas.161269998.
   PubMedGoogle Scholar
• Steiner H, Capell A, Leimer U, Haass C. 1999. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 249:266–270. http://dx.doi.org/10.1007/s004060050098.
   PubMedGoogle Scholar
• Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, Yankner BA. 2000. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2:463–465. http://dx.doi.org/10.1038/35017108.
   PubMed Web of Science ®Google Scholar
• Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B. 2000. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2:461–462. http://dx.doi.org/10.1038/35017105.
   PubMed Web of Science ®Google Scholar
• Bozkulak EC, Weinmaster G. 2009. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 29:5679–5695. http://dx.doi.org/10.1128/MCB.00406-09.
   PubMed Web of Science ®Google Scholar
• Saito T, Chiba S, Ichikawa M, Kunisato A, Asai T, Shimizu K, Yamaguchi T, Yamamoto G, Seo S, Kumano K, Nakagami-Yamaguchi E, Hamada Y, Aizawa S, Hirai H. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18:675–685. http://dx.doi.org/10.1016/S1074-7613(03)00111-0.
   PubMed Web of Science ®Google Scholar
• Gibb DR, El Shikh M, Kang DJ, Rowe WJ, El Sayed R, Cichy J, Yagita H, Tew JG, Dempsey PJ, Crawford HC, Conrad DH. 2010. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J. Exp. Med. 207:623–635. http://dx.doi.org/10.1084/jem.20091990.
   PubMed Web of Science ®Google Scholar
• Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. 2000. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105:597–605. http://dx.doi.org/10.1172/JCI8047.
   PubMed Web of Science ®Google Scholar
• Lardelli M, Dahlstrand J, Lendahl U. 1994. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech. Dev. 46:123–136. http://dx.doi.org/10.1016/0925-4773(94)90081-7.
   PubMedGoogle Scholar
• van Tetering G, Vooijs M. 2011. Proteolytic cleavage of Notch: “HIT and RUN”. Curr. Mol. Med. 11:255–269. http://dx.doi.org/10.2174/156652411795677972.
   Google Scholar
• Penton AL, Leonard LD, Spinner NB. 2012. Notch signaling in human development and disease. Semin. Cell Dev. Biol. 23:450–457. http://dx.doi.org/10.1016/j.semcdb.2012.01.010.
   PubMed Web of Science ®Google Scholar
• McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, Spinner NB. 2006. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79:169–173. http://dx.doi.org/10.1086/505332.
   PubMed Web of Science ®Google Scholar
• Simpson MA, Irving MD, Asilmaz E, Gray MJ, Dafou D, Elmslie FV, Mansour S, Holder SE, Brain CE, Burton BK, Kim KH, Pauli RM, Aftimos S, Stewart H, Kim CA, Holder-Espinasse M, Robertson SP, Drake WM, Trembath RC. 2011. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat. Genet. 43:303–305. http://dx.doi.org/10.1038/ng.779.
   PubMedGoogle Scholar
• Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. 2005. Mutations in NOTCH1 cause aortic valve disease. Nature 437:270–274. http://dx.doi.org/10.1038/nature03940.
   PubMed Web of Science ®Google Scholar
• McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt TMIII. 2007. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg. 134:290–296. http://dx.doi.org/10.1016/j.jtcvs.2007.02.041.
   PubMedGoogle Scholar
• Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269–271. http://dx.doi.org/10.1126/science.1102160.
   PubMed Web of Science ®Google Scholar
• Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649–661. http://dx.doi.org/10.1016/0092-8674(91)90111-B.
   PubMed Web of Science ®Google Scholar
• Egloff AM, Grandis JR. 2012. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy. Clin. Cancer Res. 18:5188–5195. http://dx.doi.org/10.1158/1078-0432.CCR-11-2258.
   PubMed Web of Science ®Google Scholar
• Parr C, Watkins G, Jiang WG. 2004. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int. J. Mol. Med. 14:779–786. http://dx.doi.org/10.3892/ijmm.14.5.779.
   PubMedGoogle Scholar
• McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, Daggett JJr, Cullen K, Kantoff E, Hasselbatt K, Berkowitz J, Muto MG, Berkowitz RS, Aster JC, Matulonis UA, Dinulescu DM. 2012. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc. Natl. Acad. Sci. U. S. A. 109:E2939–E2948. http://dx.doi.org/10.1073/pnas.1206400109.
   PubMed Web of Science ®Google Scholar
• Wang T, Holt CM, Xu C, Ridley C, Jones RPO, Baron M, Trump D. 2007. Notch3 activation modulates cell growth behaviour and cross-talk to Wnt/TCF signalling pathway. Cell Signal. 19:2458–2467. http://dx.doi.org/10.1016/j.cellsig.2007.07.019.
   PubMedGoogle Scholar
• Hahn S, Bruning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S. 2011. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to gamma-secretase modulators regardless of their potency and structure. J. Neurochem. 116:385–395. http://dx.doi.org/10.1111/j.1471-4159.2010.07118.x.
   PubMedGoogle Scholar
• Garcia-Ojeda ME, Klein Wolterink RG, Lemaitre F, Richard-Le Goff O, Hasan M, Hendriks RW, Cumano A, Di Santo JP. 2013. GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood 121:1749–1759. http://dx.doi.org/10.1182/blood-2012-06-440065.
   PubMedGoogle Scholar
• Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769–779. http://dx.doi.org/10.1083/jcb.200307137.
   PubMed Web of Science ®Google Scholar
• Tokumaru S, Higashiyama S, Endo T, Nakagawa T, Miyagawa JI, Yamamori K, Hanakawa Y, Ohmoto H, Yoshino K, Shirakata Y, Matsuzawa Y, Hashimoto K, Taniguchi N. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151:209–220. http://dx.doi.org/10.1083/jcb.151.2.209.
   PubMed Web of Science ®Google Scholar
• Pruessmeyer J, Martin C, Hess FM, Schwarz N, Schmidt S, Kogel T, Hoettecke N, Schmidt B, Sechi A, Uhlig S, Ludwig A. 2010. A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells. J. Biol. Chem. 285:555–564. http://dx.doi.org/10.1074/jbc.M109.059394.
   PubMedGoogle Scholar
• van Tetering G, Bovenschen N, Meeldijk J, van Diest PJ, Vooijs M. 2011. Cleavage of Notch1 by granzyme B disables its transcriptional activity. Biochem. J. 437:313–322. http://dx.doi.org/10.1042/BJ20110226.
   PubMedGoogle Scholar
• Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729–733. http://dx.doi.org/10.1038/385729a0.
   PubMed Web of Science ®Google Scholar
• Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, Umans L, Schrijvers V, Checler F, Vanderstichele H, Baekelandt V, Dressel R, Cupers P, Huylebroeck D, Zwijsen A, Van Leuven F, De Strooper B. 1999. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. U. S. A. 96:11872–11877. http://dx.doi.org/10.1073/pnas.96.21.11872.
   PubMed Web of Science ®Google Scholar
• Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R. 2000. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 5:197–206. http://dx.doi.org/10.1016/S1097-2765(00)80416-5.
   PubMed Web of Science ®Google Scholar
• Le Gall SM, Maretzky T, Issuree PD, Niu XD, Reiss K, Saftig P, Khokha R, Lundell D, Blobel CP. 2010. ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. Cell Sci. 123:3913–3922. http://dx.doi.org/10.1242/jcs.069997.
   PubMed Web of Science ®Google Scholar
• Meek B, Cloosen S, Borsotti C, Van Elssen CH, Vanderlocht J, Schnijderberg MC, van der Poel MW, Leewis B, Hesselink R, Manz MG, Katsura Y, Kawamoto H, Germeraad WT, Bos GM. 2010. In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus. Blood 115:261–264. http://dx.doi.org/10.1182/blood-2009-05-223990.
   PubMedGoogle Scholar
• Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, Wouters BG, Lammering G, Vooijs M. 2011. E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother. Oncol. 99:392–397. http://dx.doi.org/10.1016/j.radonc.2011.05.044.
   PubMed Web of Science ®Google Scholar
• Hodin CM, Verdam FJ, Grootjans J, Rensen SS, Verheyen FK, Dejong CH, Buurman WA, Greve JW, Lenaerts K. 2011. Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals. J. Pathol. 225:276–284. http://dx.doi.org/10.1002/path.2917.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Nagaoka T, Lee JM, Bianco C, Gonzales M, Castro NP, Rangel MC, Sakamoto K, Sun Y, Callahan R, Salomon DS. 2009. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1. J. Cell Biol. 187:343–353. http://dx.doi.org/10.1083/jcb.200905105.
   PubMed Web of Science ®Google Scholar
• Sahin U, Weskamp G, Zheng Y, Chesneau V, Horiuchi K, Blobel CP. 2006. A sensitive method to monitor ectodomain shedding of ligands of the epidermal growth factor receptor. Methods Mol. Biol. 327:99–113. http://dx.doi.org/10.1385/1-59745-012-X:99.
   PubMedGoogle Scholar
• Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U. 2001. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J. Biol. Chem. 276:35847–35853. http://dx.doi.org/10.1074/jbc.M103992200.
   PubMed Web of Science ®Google Scholar
• Rechsteiner M, Rogers SW. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:267–271. http://dx.doi.org/10.1016/S0968-0004(96)10031-1.
   PubMed Web of Science ®Google Scholar
• Le Gall SM, Bobe P, Reiss K, Horiuchi K, Niu XD, Lundell D, Gibb DR, Conrad D, Saftig P, Blobel CP. 2009. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol. Biol. Cell 20:1785–1794. http://dx.doi.org/10.1091/mbc.E08-11-1135.
   PubMedGoogle Scholar
• Weber S, Niessen MT, Prox J, Lullmann-Rauch R, Schmitz A, Schwanbeck R, Blobel CP, Jorissen E, de Strooper B, Niessen CM, Saftig P. 2011. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 138:495–505. http://dx.doi.org/10.1242/dev.055210.
   PubMed Web of Science ®Google Scholar
• Groot AJ, Cobzaru C, Weber S, Saftig P, Blobel CP, Kopan R, Vooijs M, Franzke CW. 2013. Epidermal ADAM17 is dispensable for notch activation. J. Invest. Dermatol. 133:2286–2288. http://dx.doi.org/10.1038/jid.2013.162.
   PubMedGoogle Scholar
• Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, Schahin-Reed D, Dow GJ, Shelton A, Stawicki S, Watts RJ, Zhang J, Choy R, Howard P, Kadyk L, Yan M, Zha J, Callahan CA, Hymowitz SG, Siebel CW. 2010. Therapeutic antibody targeting of individual Notch receptors. Nature 464:1052–1057. http://dx.doi.org/10.1038/nature08878.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Chiba S, Hosoya N, Kumano K, Saito T, Kurokawa M, Kanda Y, Hamada Y, Hirai H. 2000. Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol. Cell. Biol. 20:6913–6922. http://dx.doi.org/10.1128/MCB.20.18.6913-6922.2000.
   PubMedGoogle Scholar
• Shimizu K, Chiba S, Saito T, Kumano K, Hirai H. 2000. Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem. Biophys. Res. Commun. 276:385–389. http://dx.doi.org/10.1006/bbrc.2000.3469.
   PubMed Web of Science ®Google Scholar
• Ong CT, Cheng HT, Chang LW, Ohtsuka T, Kageyama R, Stormo GD, Kopan R. 2006. Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability. J. Biol. Chem. 281:5106–5119. http://dx.doi.org/10.1074/jbc.M506108200.
   PubMedGoogle Scholar
• Haapasalo A, Kovacs DM. 2011. The many substrates of presenilin/gamma-secretase. J. Alzheimers Dis. 25:3–28. http://dx.doi.org/10.3233/JAD-2011-101065.
   PubMed Web of Science ®Google Scholar
• Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89:629–639. http://dx.doi.org/10.1016/S0092-8674(00)80244-5.
   PubMed Web of Science ®Google Scholar
• Kostyszyn B, Cowburn RF, Seiger A, Kjaeldgaard A, Sundstrom E. 2004. Distribution of presenilin 1 and 2 and their relation to Notch receptors and ligands in human embryonic/foetal central nervous system. Brain Res. Dev. Brain Res. 151:75–86. http://dx.doi.org/10.1016/j.devbrainres.2004.04.005.
   PubMedGoogle Scholar
• Ma J, Tang X, Wong P, Jacobs B, Borden EC, Bedogni B. 2014. Noncanonical activation of notch1 protein by membrane type I matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation. J. Biol. Chem. 289:8442–8449. http://dx.doi.org/10.1074/jbc.M113.516039.
   PubMedGoogle Scholar
• Stephenson NL, Avis JM. 2012. Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region. Proc. Natl. Acad. Sci. U. S. A. 109:E2757–E2765. http://dx.doi.org/10.1073/pnas.1205788109.
   PubMed Web of Science ®Google Scholar
• Sulis ML, Saftig P, Ferrando AA. 2011. Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL. Leukemia 25:1564–1569. http://dx.doi.org/10.1038/leu.2011.130.
   PubMedGoogle Scholar